Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »
Shares of CureVac NV rose Thursday after the German biotech company said it was in advanced talks to deliver at least 225 million doses of a potential Covid-19 vaccine to EU member states. CureVac said talks with the EC, the executive arm of the European Union, include an option to …
Read More »
FILE PHOTO: The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company’s listing on the New York Stock Exchange (NYSE) in New York, US, September 17, 2019. REUTERS / Brendan McDermid / File Photo (Reuters) – Johnson & Johnson (JNJ.N) …
Read More »
Johnson & Johnson plans to launch in late September what may be the largest clinical trial to date against a coronavirus vaccine, enrolling up to 60,000 people worldwide to test whether the experimental shot safely protects against Covid-19. The targeted enrollment, reported on a government database and confirmed by the …
Read More »
Pope Francis warned Wednesday against any chance that rich people would be given priority for a coronavirus vaccine. “The pandemic is a crisis. You are not getting the same out of it – even better than worse,” Francis said, adding impromptu remarks to his planned speech to his weekly audience. …
Read More »